Get the app!
Back to Trades
Total Value
$2.5M
Filing Date
Oct 30, 2025
1 transactions

Trade Summary

On Oct 28, 2025, Finke Thomas M, Director, reported $2.5M of Venu Holding Corp (VENU) across 1 transactions. The filing covers company securities and reflects balanced net activity of $0. Reported prices ranged from $10.00. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Company Information

Company Name
Venu Holding Corp
Ticker Symbol
VENU
CIK
0001770501

Insider Information

Role
Director
Location
COLORADO SPRINGS, CO

Filing Details

Filing Date
Oct 30, 2025
Transaction Date
Oct 28, 2025
Accession Number
0001493152-25-020283
Form Type
4

Derivative Transactions

DateSecuritySharesExercise PriceTypeValue
VENU derivative250,000$10.00Grant/Award$2.5M

Want live alerts when Finke Thomas M trades again?

Download Insider Trades to track VENU, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

Footnotes

  1. (F1)This option was approved by the board of directors (the "Board") of Venu Holding Corporation (the "Issuer") and is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d)(1) promulgated thereunder.
  2. (F2)This option grant was approved by the Issuer's Board on May 1, 2025, subject to shareholder approval of an amendment to the Issuer's Amended and Restated 2023 Omnibus Incentive Compensation Plan (the "Plan"), which the option was granted under, to increase the number of shares of the Company's common stock (the "Common Stock") reserved for issuance under the Plan. The Issuer's shareholders approved such amendment to the Plan on October 28, 2025 (the "Grant Effective Date").
  3. (F3)Of the 250,000 shares of Common Stock underlying this option, 50,000 shares vested immediately on the Grant Effective Date. Thereafter, 50,000 shares will vest on each annual anniversary of the effective date of the Reporting Person's appointment to the Board, which occurred on May 5, 2025.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.